Tessa Gargett
5PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 16, 2024
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.Tessa Gargett, Nga T H Truong, Bryan Gardam
|Sep 27, 2022
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.Tessa Gargett, Lisa M Ebert, Nga T H Truong
|Aug 16, 2021
Correction to: Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.Vasilios Liapis, William Tieu, Nicole L Wittwer
|Jul 07, 2021
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.Vasilios Liapis, William Tieu, Nicole L Wittwer
|Jul 18, 2018
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma.Tessa Gargett, M Nazim Abbas, Paul Rolan
Pageof 1
Frequent Collaborators
4 joint publications
Michael P Brown
3 joint publications
Nicole L Wittwer
2 joint publications
Vasilios Liapis
2 joint publications
William Tieu
2 joint publications
Andreas Evdokiou
2 joint publications
Stacey E Rudd
2 joint publications
Paul S Donnelly
2 joint publications
Alexander H Staudacher
2 joint publications
Lisa M Ebert
